Plain-English translation of NCT06080841 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing curcumin, a natural compound found in turmeric spice, to see if it can make standard cervical cancer treatment more effective. Researchers believe curcumin might help activate a protein in your body called p53 that fights cancer cells and makes them die. You would take the medication by mouth in different doses while receiving your regular chemotherapy and radiation treatment.
Many women with advanced cervical cancer don't respond well enough to current standard treatment, and some cancers become resistant to it. This trial is exploring whether the medication could reactivate your body's natural cancer-fighting defenses to improve treatment outcomes and give women better options.
You likely qualify if…
You likely don't qualify if…
You would be assigned to one of six groups, each taking a different dose of the curcumin supplement — either alone or combined with a booster ingredient called piperine — while you receive your standard chemotherapy and radiation treatment. You would take the supplement by mouth daily and attend scheduled visits for blood tests and imaging scans to see how well the treatment is working. The trial involves about 30 women total and runs alongside your regular cancer care at the National Institute of Cancerología in Mexico.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Mexico